2010The Journal of Clinical PsychiatryRequires access

Controlled study on depression comorbid with anxiety treated by venlafaxine

Wen Su-ron

Open publisher page 0 citations

Abstract

Objective:To detect the efficacy and safety of venlafaxine and proxetine in the treatment of depression comorbid with anxiety.Method:73 patients with anxiety and depression were divided randomly into two groups(35 cases in study group;38 cases in control group).The study group was taken venlafaxine,and the control group was taken paroxitine.They were observed for 8 weeks.Hamilton depression scale(HAMD),Hamilton anxiety scale(HAMA)and treatment emergent symptoms scale(TESS)were used to evaluate the efficacies and side effects.Results:After 8 weeks treatment,study group showed improvement rate for depression and for anxiety which was similar to in control group(χ2=0.69,0.90;P0.05).The two groups showed significant decreases on HAMD and HAMA scores(P0.05 or P0.01)and light side effects.Conclusion:Venlafaxine and paroxitine have definite efficacy and safety for combined anxiety and depression with better patients' compliance.

About this research paper

What this paper is about

Objective:To detect the efficacy and safety of venlafaxine and proxetine in the treatment of depression comorbid with anxiety.Method:73 patients with anxiety and depression were divided randomly into two groups(35 cases in study group;38 cases in control group).The study group was taken venlafaxine,and the control group was taken paroxitine.They were observed for 8 weeks.Hamilton depression scale(HAMD),Hamilton anxiety scale(HAMA)and treatment emergent symptoms scale(TESS)were used to evaluate the efficacies and side effects.Results:After 8 weeks treatment,study group showed improvement rate for depression and for anxiety which was similar to in control group(χ2=0.69,0.90;P0.05).The two groups showed significant decreases on HAMD and HAMA scores(P0.05 or P0.01)and light side effects.Conclusion:Venlafaxine and paroxitine have definite efficacy and safety for combined anxiety and depression with better patients' compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To detect the efficacy and safety of venlafaxine and proxetine in the treatment of depression comorbid with anxiety.Method:73 patients with anxiety and depression were divided randomly into two groups(35 cases in study group;38 cases in control group).The study group was taken venlafaxine,and the control group was taken paroxitine.They were observed for 8 weeks.Hamilton depression scale(HAMD),Hamilton anxiety scale(HAMA)and treatment emergent symptoms scale(TESS)were used to evaluate the efficacies and side effects.Results:After 8 weeks treatment,study group showed improvement rate for depression and for anxiety which was similar to in control group(χ2=0.69,0.90;P0.05).The two groups showed significant decreases on HAMD and HAMA scores(P0.05 or P0.01)and light side effects.Conclusion:Venlafaxine and paroxitine have definite efficacy and safety for combined anxiety and depression with better patients' compliance.

Key concepts: Hamd, Venlafaxine, Anxiety, Depression (economics), Hamilton depression scale, Psychology, Internal medicine, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Controlled study on depression comorbid with anxiety treated by venlafaxine — Research Paper | ScholarLens